Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled nano-particulate dry powder anti-tuberculosis treatment
TCTR20190404002Phase 2Recruiting
- Sponsor
- Government Pharmaceutical Organization
- Start
- Jan 2016
- Countries
- 1
01
Overview
Phase 2 trial in Tuberculosis (TB), sponsored by Government Pharmaceutical Organization. Started Jan 2016; status: recruiting.
02
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on TCTR20190404002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190404002.